Symphony Biosciences Inc.
Los Angeles, CA
- UEI
- NUGCJMCBBHV1
- CAGE
- 90LH7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 570 Westwood Plaza, Los Angeles, CA 90095, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Immunomodulatory biomaterial to enhancing t-cell responses to triple negative breast cancer | National Cancer Institute (NIH) | $5,358,393 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Center For The Advancement Of Science In Space, Inc. | 80JSC018M0005 | $295,000 |
Quick answers
Is Symphony Biosciences Inc. registered in SAM.gov?
Yes. Symphony Biosciences Inc.'s SAM.gov registration is active through September 3, 2027.
What is Symphony Biosciences Inc.'s most recent federal award?
Symphony Biosciences Inc.'s most recent federal grant award is Immunomodulatory biomaterial to enhancing t-cell responses to triple negative breast cancer (R44CA281563), from National Cancer Institute (NIH), on May 1, 2023.
On GovTribe
See Symphony Biosciences Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors